Retrospective Review Clinical Use of a cfDNA Blood Test for Identification of Targetable Molecular Alterations in Patients with Lung Cancer

被引：2
|
作者：
Tran, Hai [1 ]
Zhang, Jianjun [1 ]
Vasquez, Marya [1 ]
Fossella, Frank [1 ]
Simon, George [1 ]
Tsao, Anne [1 ]
Gibbons, Don Lynn [1 ]
Elamin, Yasir [1 ]
Banks, Kimberly [2 ]
Lanman, Richard [2 ]
Papadimitrakopoulou, Vassiliki [1 ]
Heymach, John [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Thorac & Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Guardant Hlth Inc, Redwood City, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
lung cancer; cfDNA; ctDNA; molecular alterations;
D O I：
10.1016/j.jtho.2016.11.1311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03b-030
引用
收藏
页码：S952 / S952
页数：1
相关论文
共 50 条
  • [1] Matched Thai Lung Cancer Patients Tissue and cfDNA Molecular Profile by NGS
    Trachu, N.
    Detarkom, S.
    Incharoen, P.
    Kamprerasart, K.
    Iemwimangsa, N.
    Arsa, L.
    Chantratita, W.
    Muntham, D.
    Sirachainan, E.
    Reungwetwattana, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S955 - S955
  • [2] Prevalence of EGFR Alterations in Chilean Lung Cancer Patients: A Retrospective Study
    Gejman, R.
    Bravo, M. L.
    Munoz, M.
    Retamal, I.
    Nervi, B.
    Sanchez, C.
    Ibanez, C.
    Pena, J.
    Madrid, J.
    Briones, J.
    Perez, P.
    Garrido, M.
    Pinto, M.
    Galindo, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S716 - S716
  • [3] Retrospective review of patients with lung cancer presenting emergently
    Pettit, Nicholas R.
    Noriega, Andrea
    Vander Missen, Marissa Rose
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 71 : 129 - 133
  • [4] Retrospective review of patients with lung cancer identified in the emergency department
    Pettit, Nicholas
    Cinbat, Melisa
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 50 : 394 - 398
  • [5] Current clinical trials and patent update on lung cancer: a retrospective review
    Batra, Harshul
    Pawar, Shrikant
    Bahl, Dherya
    LUNG CANCER MANAGEMENT, 2021, 10 (02)
  • [6] Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice
    Gonzalez de Aledo-Castillo, Jose Manuel
    Arcocha, Ainara
    Victoria, Ivan
    Isabel Martinez-Puchol, Ana
    Sanchez, Cristina
    Jares, Pedro
    Felipe Rodriguez, Gabriel
    Vinolas, Nuria
    Reyes, Roxana
    Reguart, Noemi
    Anton Puig-Butille, Joan
    JOURNAL OF THORACIC DISEASE, 2021, 13 (03) : 1658 - 1670
  • [7] A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer
    Sekine, Ikuo
    Minna, John D.
    Nishio, Kazuto
    Tamura, Tomohide
    Saijo, Nagahiro
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (01) : 31 - 37
  • [8] Clinical and Histopathological Features of Thyroid Cancer with TERT Promoter Molecular Alterations in Isolation Versus with Concurrent Molecular Alterations: A Multicenter Retrospective Study
    Steinberg, Emily
    Dimitstein, Orr
    Morand, Gregoire B.
    Forest, Veronique-Isabelle
    da Silva, Sabrina D.
    Pusztaszeri, Marc
    Alohali, Sama
    Payne, Richard J.
    CANCERS, 2024, 16 (20)
  • [9] Clinical test on circulating tumor cells in peripheral blood of lung cancer patients, based on novel immunomagnetic beads
    Wang, Bo
    Wang, Bin
    Zhang, Daoyun
    Guo, Hongyin
    Zhang, Lianbin
    Zhou, Wenpeng
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2016, 44 (03) : 892 - 897
  • [10] Clinicopathological and molecular characteristics of patients with hypermutant lung cancer: A retrospective cohort study
    Zhang, Hongbin
    Wang, Yuan
    Ji, Qiaoxia
    Cai, Hongmei
    Liang, Xiangcun
    Xie, Jiong
    Li, Hua
    Wang, Jun
    Zhu, Guiyun
    Tian, Erpeng
    Zhu, Lingling
    Yuan, Mingming
    Chen, Rongrong
    Zhao, Min
    ONCOLOGY LETTERS, 2021, 21 (04)
12345